论文部分内容阅读
曹韵贞教授曾参与何大一教授主持的艾滋病原发性感染、艾滋病长期生存者、艾滋病母婴传播、艾滋病表面抗原差异学、“鸡尾酒疗法”的病毒学等方面的专题研究。1998年受邀回国后为我国艾滋病防治初创工作做出巨大贡献。她介绍,目前研发的方向首先是减少药物的不良反应和降低耐药性,其次是改善病人的依从性。疫苗的研究已经成为全球艾滋病防治工作的首要任务,目前有25种以上的疫苗已进入人体实验。艾滋病疫苗在安全性和激发免疫能力等方面已经得到证实,但是离成功还有相当距离。在这种情况下,药物的研制还是非常重要的。就目前而言治疗也是一种预防。在防治艾滋病过程中,中国有自己的优势。文详见第4版《声音·焦点直击》。
Professor Cao Yunzhen participated in Professor He Daili presided over the primary AIDS-related infections, AIDS, long-term survivors, mother-to-child transmission of HIV, AIDS surface antigen differentiation, “Cocktail therapy” virology research. After being invited back to China in 1998, he made great contributions to the start-up work of AIDS prevention in our country. She introduced that the current direction of research and development is to reduce the adverse drug reactions and reduce drug resistance, followed by improving patient compliance. Vaccine research has become the top priority of global AIDS prevention and control work. At present, more than 25 kinds of vaccines have entered human experiments. AIDS vaccine has been confirmed in terms of safety and immunity, but there is still a long way to success. In this case, the development of the drug is still very important. For the moment treatment is also a prevention. In the AIDS prevention and control process, China has its own advantages. For more information, see the 4th edition “Sound Focus”.